These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 10639016
1. COX-2 is not involved in thromboxane biosynthesis by activated human platelets. Patrignani P, Sciulli MG, Manarini S, Santini G, Cerletti C, Evangelista V. J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016 [Abstract] [Full Text] [Related]
2. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T. Circulation; 2003 Aug 05; 108(5):542-7. PubMed ID: 12874188 [Abstract] [Full Text] [Related]
3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P. Circulation; 2004 Mar 30; 109(12):1468-71. PubMed ID: 15037526 [Abstract] [Full Text] [Related]
4. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Panara MR, Padovano R, Sciulli MG, Santini G, Renda G, Rotondo MT, Pace A, Patrono C, Patrignani P. Clin Pharmacol Ther; 1998 Jun 30; 63(6):672-81. PubMed ID: 9663182 [Abstract] [Full Text] [Related]
6. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. Sciulli MG, Renda G, Capone ML, Tacconelli S, Ricciotti E, Manarini S, Evangelista V, Rebuzzi A, Patrignani P. Clin Pharmacol Ther; 2006 Aug 30; 80(2):115-25. PubMed ID: 16890573 [Abstract] [Full Text] [Related]
11. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. Greenberg HE, Gottesdiener K, Huntington M, Wong P, Larson P, Wildonger L, Gillen L, Dorval E, Waldman SA. J Clin Pharmacol; 2000 Dec 05; 40(12 Pt 2):1509-15. PubMed ID: 11185674 [Abstract] [Full Text] [Related]
12. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis. Tanaka N, Sato T, Fujita H, Morita I. Arterioscler Thromb Vasc Biol; 2004 Mar 05; 24(3):607-12. PubMed ID: 14726416 [Abstract] [Full Text] [Related]
13. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Belton OA, Duffy A, Toomey S, Fitzgerald DJ. Circulation; 2003 Dec 16; 108(24):3017-23. PubMed ID: 14638539 [Abstract] [Full Text] [Related]
17. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum. Beubler E, Schuligoi R, Chopra AK, Ribardo DA, Peskar BA. J Pharmacol Exp Ther; 2001 Jun 16; 297(3):940-5. PubMed ID: 11356914 [Abstract] [Full Text] [Related]
18. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. Giuliano F, Warner TD. J Pharmacol Exp Ther; 2002 Dec 16; 303(3):1001-6. PubMed ID: 12438520 [Abstract] [Full Text] [Related]